Karuna Therapeutics (KRTX) SEC Filings & 10K Form

$329.83
0.00 (0.00%)
(As of 04/1/2024)

Recent Karuna Therapeutics SEC Filings

DateFilerForm TypeView
03/28/2024
3:06 PM
Karuna Therapeutics (Filer)
Form 15-12G
03/18/2024
3:30 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
Kane William P Jr (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
Karuna Therapeutics (Issuer)
Meury William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
Brown Jason Parker (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
COUGHLIN CHRISTOPHER J (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
Karuna Therapeutics (Issuer)
PAUL STEVEN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
Karuna Therapeutics (Issuer)
Miller Andrew Craig (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
HEALY JAMES (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
JONAS JEFFREY M (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
Karuna Therapeutics (Issuer)
OLSON LAURIE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
Karuna Therapeutics (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
Karuna Therapeutics (Issuer)
Torres Denice (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:31 PM
Karuna Therapeutics (Issuer)
Wheadon David E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
8:19 AM
Karuna Therapeutics (Filer)
Form S-8 POS
03/18/2024
8:19 AM
Karuna Therapeutics (Filer)
Form S-8 POS
03/18/2024
8:19 AM
Karuna Therapeutics (Filer)
Form S-8 POS
03/18/2024
8:19 AM
Karuna Therapeutics (Filer)
Form S-8 POS
03/18/2024
8:19 AM
Karuna Therapeutics (Filer)
Form S-8 POS
03/18/2024
8:04 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
8:08 AM
Karuna Therapeutics (Filer)
Form POSASR
03/18/2024
8:10 AM
Karuna Therapeutics (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
03/14/2024
6:26 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
3:15 PM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
4:10 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:01 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
5:01 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
5:02 AM
Karuna Therapeutics (Filer)
Form DEFA14A
02/26/2024
5:15 PM
Karuna Therapeutics (Issuer)
PAUL STEVEN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
5:39 AM
Karuna Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
5:32 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
3:42 PM
Karuna Therapeutics (Issuer)
Miller Andrew Craig (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:45 PM
Brown Jason Parker (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:50 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Kane William P Jr (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:37 PM
Karuna Therapeutics (Issuer)
Meury William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
4:09 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
4:11 PM
Karuna Therapeutics (Issuer)
Miller Andrew Craig (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
4:13 PM
Karuna Therapeutics (Issuer)
PAUL STEVEN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
11:03 AM
Karuna Therapeutics (Subject)
Form SC 13G/A
02/12/2024
11:25 AM
Capital International Investors (Filed by)
Karuna Therapeutics (Subject)
Form SC 13G/A
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>
02/09/2024
4:19 PM
Capital International Investors (Filed by)
Karuna Therapeutics (Subject)
Form SC 13G/A
02/08/2024
10:56 AM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
3:12 PM
Karuna Therapeutics (Filer)
Form DEFM14A
01/31/2024
1:08 PM
BlackRock Inc. (Filed by)
Karuna Therapeutics (Subject)
Form SC 13G
01/22/2024
5:05 AM
Karuna Therapeutics (Filer)
Form PREM14A
01/10/2024
7:53 AM
FMR LLC (Filed by)
Karuna Therapeutics (Subject)
Form SC 13G/A
01/09/2024
3:34 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:18 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/29/2023
3:43 PM
Kane William P Jr (Reporting)
Karuna Therapeutics (Issuer)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
3:42 PM
Karuna Therapeutics (Issuer)
Meury William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
5:09 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/22/2023
4:20 PM
Karuna Therapeutics (Filer)
Form DEFA14A
12/22/2023
4:20 PM
Karuna Therapeutics (Filer)
Form DEFA14A
12/22/2023
4:07 PM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
3:36 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Karuna Therapeutics (Subject)
Form DFAN14A
12/22/2023
3:21 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Karuna Therapeutics (Subject)
Form DFAN14A
12/22/2023
3:22 PM
Karuna Therapeutics (Filer)
Form DEFA14A
12/22/2023
3:28 PM
Karuna Therapeutics (Filer)
Form DEFA14A
12/22/2023
7:31 AM
Karuna Therapeutics (Filer)
Form DEFA14A
12/22/2023
7:26 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2023
3:56 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2023
2:24 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2023
3:28 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/28/2023
4:39 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
5:09 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2023
4:15 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
5:45 AM
Karuna Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2023
5:36 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2023
3:53 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
10:52 AM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2023
4:19 PM
Brown Jason Parker (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
4:05 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2023
3:41 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2023
3:40 PM
JONAS JEFFREY M (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2023
3:49 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
4:14 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/03/2023
5:45 AM
Karuna Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2023
5:37 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2023
4:53 PM
JONAS JEFFREY M (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:35 PM
BlackRock Inc. (Filed by)
Karuna Therapeutics (Subject)
Form SC 13G/A
07/05/2023
3:44 PM
JONAS JEFFREY M (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:02 PM
JONAS JEFFREY M (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2023
3:03 PM
Karuna Therapeutics (Subject)
OLSON LAURIE J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/22/2023
3:18 PM
Karuna Therapeutics (Issuer)
Wheadon David E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:07 PM
Karuna Therapeutics (Issuer)
OLSON LAURIE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:09 PM
Karuna Therapeutics (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:11 PM
COUGHLIN CHRISTOPHER J (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:13 PM
JONAS JEFFREY M (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:16 PM
HEALY JAMES (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
4:15 PM
Karuna Therapeutics (Filer)
Form S-3ASR
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>
06/21/2023
3:05 PM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
7:56 PM
Karuna Therapeutics (Subject)
Sofinnova Venture Partners X, L.P. (Filed by)
Form SC 13D/A
06/20/2023
7:56 PM
HEALY JAMES (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
2:48 PM
Capital International Investors (Filed by)
Karuna Therapeutics (Subject)
Form SC 13G
05/23/2023
4:04 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/04/2023
5:49 AM
Karuna Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2023
5:37 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2023
6:12 AM
Karuna Therapeutics (Filer)
Form ARS
04/27/2023
5:58 AM
Karuna Therapeutics (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:KRTX) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners